VES001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for VES001, covering 2024-08-22 to 2025-08-24. Get the full timeline:
Most recent: Clinical Trial Update: Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 [Phase 1]